KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Medtronic (MDT) Other Operating Expenses (2017 - 2026)

Medtronic's Other Operating Expenses history spans 11 years, with the latest figure at -$35.0 million for Q1 2026.

  • On a quarterly basis, Other Operating Expenses fell 800.0% to -$35.0 million in Q1 2026 year-over-year; TTM through Jan 2026 was -$142.0 million, a 67.65% increase, with the full-year FY2025 number at $23.0 million, up 104.96% from a year prior.
  • Other Operating Expenses hit -$35.0 million in Q1 2026 for Medtronic, down from -$22.0 million in the prior quarter.
  • Over the last five years, Other Operating Expenses for MDT hit a ceiling of $125.0 million in Q1 2023 and a floor of -$477.0 million in Q2 2024.
  • Historically, Other Operating Expenses has averaged -$30.4 million across 5 years, with a median of -$15.0 million in 2025.
  • Biggest five-year swings in Other Operating Expenses: skyrocketed 561.9% in 2022 and later tumbled 6900.0% in 2025.
  • Tracing MDT's Other Operating Expenses over 5 years: stood at $97.0 million in 2022, then plummeted by 68.04% to $31.0 million in 2023, then grew by 9.68% to $34.0 million in 2024, then crashed by 164.71% to -$22.0 million in 2025, then crashed by 59.09% to -$35.0 million in 2026.
  • Business Quant data shows Other Operating Expenses for MDT at -$35.0 million in Q1 2026, -$22.0 million in Q4 2025, and -$70.0 million in Q3 2025.